Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

ACR ExamRheum

Gout: What Urate-Lowering Therapy Should Be the First-Line Treatment?

From the College  |  July 27, 2022

MIA Studio / shutterstock.com

Acquired Heart Disease in Kawasaki Disease

Staff  |  June 29, 2022

Following two infusions of 1,000 mg rituximab eight weeks apart, the patient’s symptoms resolved.

Gout: Infusion Reactions

Staff  |  May 25, 2022

The Microbiome in Pediatric Rheumatic Diseases

When to Start Biologics for pJIA

Staff  |  January 4, 2022

Methotrexate

Maxed Out Methotrexate?

Staff  |  November 22, 2021

How to Estimate Disease Burden in PsA

Staff  |  November 12, 2021

RA: When Should DMARDs Be Started?

Staff  |  October 26, 2021

Dr. Truslow performs a routine examination of the hand of a patient with rheumatoid arthritis.

RA: To Taper or Not to Taper DMARDs?

Staff  |  October 1, 2021

MDGRPHaCS / shutterstock.com

RA Management: What’s the First-Line Treatment Option in Patients with Low Disease Activity?

Staff  |  August 31, 2021

New Vasculitis Guidelines: How Should You Treat PAN?

Staff  |  July 29, 2021

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences